NG2/CSPG4 promotes resistance to therapy in glioblastoma multiforme

被引：0
|
作者：
Heywood, R. [1 ]
Watts, C. [1 ]
机构：
[1] Cambridge Ctr Brain Repair, Cambridge, England
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3330
引用
收藏
页码：S784 / S784
页数：1
相关论文
共 50 条
  • [31] Myelin Debris Stimulates NG2/CSPG4 Expression in Bone Marrow-Derived Macrophages in the Injured Spinal Cord
    Liu, Yang
    Hammel, Grace
    Shi, Minjun
    Cheng, Zhijian
    Zivkovic, Sandra
    Wang, Xiaoqi
    Xu, Pingyi
    He, Xijing
    Guo, Bing
    Ren, Yi
    Zuo, Li
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [32] Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage
    Hsu, Shu-Hsuan Claire
    Nadesan, Puviindran
    Puviindran, Vijitha
    Section, William B. Stallcup
    Kirsch, David G.
    Alman, Benjamin A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (07) : 2466 - 2475
  • [33] CSPG4/NG2在胶质瘤免疫抑制治疗中的研究进展
    康剑
    李宗阳
    陈垒
    李维平
    中国微侵袭神经外科杂志, 2017, 22 (01) : 46 - 48
  • [34] Intracranial administration of activated NK-cells and mAb9.2.27 against NG2/CSPG4 activates microglial cytotoxicity and prolongs survival in glioblastoma xenograft model
    Poli, Aurelie
    Wang, Jian
    Domingues, Olivia
    Yan, Tao
    Thorsen, Frits
    Brekke-Rygg, Cecilie
    Hentges, Francois
    Pedersen, Paal Henning
    Zimmer, Jacques
    Enger, Per Oyvind
    Chekenya, Martha
    CANCER RESEARCH, 2012, 72
  • [35] Chondroitin Sulfate Proteoglycan Abnormalities in Schizophrenia: Involvement of NG2 (nerve/glial Antigen 2-CSPG4)
    Berretta, Sabina
    Pantazopoulos, Harry
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S541 - S542
  • [36] Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
    Farnedi, Anna
    Rossi, Silvia
    Bertani, Nicoletta
    Gulli, Mariolina
    Silini, Enrico Maria
    Mucignat, Maria Teresa
    Poli, Tito
    Sesenna, Enrico
    Lanfranco, Davide
    Montebugnoli, Lucio
    Leonardi, Elisa
    Marchetti, Claudio
    Cocchi, Renato
    Ambrosini-Spaltro, Andrea
    Foschini, Maria Pia
    Perris, Roberto
    BMC CANCER, 2015, 15
  • [37] Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
    Anna Farnedi
    Silvia Rossi
    Nicoletta Bertani
    Mariolina Gulli
    Enrico Maria Silini
    Maria Teresa Mucignat
    Tito Poli
    Enrico Sesenna
    Davide Lanfranco
    Lucio Montebugnoli
    Elisa Leonardi
    Claudio Marchetti
    Renato Cocchi
    Andrea Ambrosini-Spaltro
    Maria Pia Foschini
    Roberto Perris
    BMC Cancer, 15
  • [38] NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells
    Catarina Rippe
    Björn Morén
    Li Liu
    Karin G. Stenkula
    Johan Mustaniemi
    Malin Wennström
    Karl Swärd
    Scientific Reports, 11
  • [39] NG2/CSPG4, CD146/MCAM and VAP1/AOC3 are regulated by myocardin-related transcription factors in smooth muscle cells
    Rippe, Catarina
    Moren, Bjoern
    Liu, Li
    Stenkula, Karin G.
    Mustaniemi, Johan
    Wennstrom, Malin
    Sward, Karl
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] Glioblastoma Multiforme Therapy and Mechanisms of Resistance
    Ramirez, Yulian P.
    Weatherbee, Jessica L.
    Wheelhouse, Richard T.
    Ross, Alonzo H.
    PHARMACEUTICALS, 2013, 6 (12): : 1475 - 1506
12345